, Singapore

Triple threat: Singapore economy at risk from debt, deflation, and deteriorating demographics

Debt-to-GDP ratio is at 251%.

Singapore is vulnerable to the triple threat of rising debt, intensifying deflation, and deteriorating dynamics, a report by Morgan Stanley revealed.

“Weak demographics and productivity dynamic is weighing on growth in the background, while the combination of high debt and deflationary pressures is adding to these pressures of managing the debt and growth dynamic,” stated the report.

The report showed that Singapore’s debt-to-GDP ratio surged to 251% in 2014 from just 174% in 2007. This figure is the third-highest in Asia excluding Japan and the highest in the ASEAN.

Meanwhile. working-age population growth is expected to slip into negative territory after 2020.

Singapore’s consumer price index has been in the red since November, and the central bank has recently adjusted its 2015 inflation forecast to -0.5–0.5% from 0.5-1.5%. 

Join Singapore Business Review community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Top News

DBS and OCBC expected to deliver steady Q1 net profits
Their net interest margins will ease as a result of their Hong Kong loans.
Singapore's maritime cluster navigates towards digital, green future
Adapting to emerging challenges, such as the adoption of alternative fuels, is deemed crucial for the country's maritime sector.
Shipping & Marine
SCG and A*STAR unveil joint labs for cellular immunotherapy enhancement
The partnership has a funding of nearly $30m supported under Singapore's Research, Innovation and Enterprise 2025 plan.
Healthcare